Effects of Omega 3 in Hemodialysis Patients

March 2, 2016 updated by: Laboratoire Régional de Nutrition Humaine

Effets of Fish Oil on Metabolic Fate of an Oral Glucose Load in Patients With End Stage Renal Disease Undergoing Hemodialysis

The aim of the study was to determine the effects of a 3-week fish oil oral supplementation on the metabolic fate and thermogenic effect of an oral glucose load in hemodialysis patients.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment

8

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • France
      • Brest, France, F-29200
        • Laboratoire Régional de Nutrition Humaine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • hemodialysis at least 6 months duration end stage renal disease

Exclusion Criteria:

  • - Age < 18 y ou > 75 y
  • Hemodialysis < 6 months
  • Diabetes, obesity
  • allergy to fish
  • Asthma
  • glucocorticoïds, propranolol,, Immunosuppressive drugs, Insulin, Somatostatin
  • erythropoïetin < 3 months
  • Cancer
  • Hemoglobin < 11 g/l
  • disease < 1 month
  • pregnancy
  • respiratory insufficiency
  • intensive sport practice
  • refusal

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Screening
  • Allocation: Non-Randomized
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
plasma glucose utilization
glucose-induced thermogenesis

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Laboratoire Régional de Nutrition Humaine

Investigators

  • Principal Investigator: Jacques Delarue, MD,PhD, CHU Cavale Blanche F-29200 Brest

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2003

Study Completion

November 1, 2003

Study Registration Dates

First Submitted

February 3, 2007

First Submitted That Met QC Criteria

February 3, 2007

First Posted (Estimate)

February 6, 2007

Study Record Updates

Last Update Posted (Estimate)

March 3, 2016

Last Update Submitted That Met QC Criteria

March 2, 2016

Last Verified

February 1, 2007

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • HDW3

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe